We are currently setting up a research and clinical structure to offer cellular treatment for patients with cancer with a strong pre-clinical and clinical interaction i) to better understand the tumor-host relationship, ii) to map the patients 'private' mutational burden and iii) to identify the best immunological strategy to fight off cancer using molecular methods, gene transfer, biological therapy guided by imaging technologies. Data from infectious diseases aid to better understand the tumor-host relationship and aid to gauge biologically and clinically relevant HDTs (host directed therapy) concepts.
Cell culture, Deep TCR Sequencing, Whole Tumor DNA exome sequencing, RNAseq, high content flow cytometry and cell-cell interaction analysis, computional and software development.
Join a team dedicated to strong local, national and international research and clinical collaborations to develop better therapeutic options for patients with 'difficult-to-treat-cancer'. We are looking for individuals with strong background in bioinformatics, clinical geneticists, clinical immunology and T-cell biology / molecular biology.